| Price | 10.73 |
| Price Change Today | +$0.54 (+5.30%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $10.23 |
| Previous Close | $10.19 |
| Daily Range | $10.02 - $10.73 |
| 52-Week Range | $9.67 - $37.84 |
| Volume | 933,338 |
| InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment